Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.53 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL297237 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL707139 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL297935 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL430004 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL297738 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL6575811 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL37427 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL705126 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL6012088 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B | |
| SCHEMBL31601999 | 1.00 | ALOX5 (0.53) | ALOX5PIK3CDFAAHMGLLADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140243765-A1 | PERCUTANEOUSLY ABSORBABLE PREPARATION CONTAINING FENTANYL AND HOMOLOGUE THEREOF | SAMYANG BIOPHARMACEUTICALS CORPORATION (KR) | 2014-08-28 | — | — | US | claimed |
| US-20130165875-A1 | TRANSDERMAL ABSORPTION PREPARATION | ICURE PHARMACEUTICAL INC. (KR) | 2013-06-27 | — | — | US | claimed |
| EP-2561865-A2 | TRANSDERMAL ABSORPTION PREPARATION | Icure Pharmaceutical Inc. (KR) | 2013-02-27 | — | — | EP | claimed |
| US-20180318232-A1 | FORMULATION FOR PERCUTANEOUS ADMINISTRATION CONTAINING FENTANYL AND ANALOGUE THEREOF | SAMYANG BIOPHARMACEUTICALS CORPORATION (KR) | 2018-11-08 | — | — | US | disclosed |
| EP-2759294-B1 | Formulation for percutaneous administration containing Fentanyl and analague thereof | SAMYANG BIOPHARMACEUTICALS (KR) | 2017-11-01 | — | — | EP | disclosed |
| US-20140243765-A1 | PERCUTANEOUSLY ABSORBABLE PREPARATION CONTAINING FENTANYL AND HOMOLOGUE THEREOF | SAMYANG BIOPHARMACEUTICALS CORPORATION (KR) | 2014-08-28 | — | — | US | disclosed |
| EP-2759294-A1 | PERCUTANEOUSLY ABSORBABLE PREPARATION CONTAINING FENTANYL AND A HOMOLOGUE THEREOF | Transderm Inc. (KR) | 2014-07-30 | — | — | EP | disclosed |
| US-20130165875-A1 | TRANSDERMAL ABSORPTION PREPARATION | ICURE PHARMACEUTICAL INC. (KR) | 2013-06-27 | — | — | US | disclosed |
| EP-2561865-A2 | TRANSDERMAL ABSORPTION PREPARATION | Icure Pharmaceutical Inc. (KR) | 2013-02-27 | — | — | EP | disclosed |
| EP-1003499-B1 | DICLOFENAC SOLUTION FOR TOPICAL APPLICATION | PERMAMED AG (CH) | 2001-09-26 | — | — | EP | disclosed |
| EP-1003499-A1 | DICLOFENAC SOLUTION FOR TOPICAL APPLICATION | Caan Aktiengesellschaft (LI) | 2000-05-31 | — | — | EP | disclosed |
| WO-1998057624-A1 | DICLOFENAC SOLUTION FOR TOPICAL APPLICATION | CAAN AKTIENGESELLSCHAFT (LI) | 1998-12-23 | — | — | WO | disclosed |